↓ Skip to main content

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

Overview of attention for article published in BMC Cancer, October 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
Published in
BMC Cancer, October 2019
DOI 10.1186/s12885-019-6185-0
Pubmed ID
Authors

Louie Semaan, Navneet Mander, Michael L. Cher, Sreenivasa R. Chinni

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 24%
Researcher 5 15%
Student > Bachelor 4 12%
Unspecified 2 6%
Professor 2 6%
Other 4 12%
Unknown 8 24%
Readers by discipline Count As %
Medicine and Dentistry 11 33%
Biochemistry, Genetics and Molecular Biology 6 18%
Unspecified 2 6%
Nursing and Health Professions 1 3%
Economics, Econometrics and Finance 1 3%
Other 1 3%
Unknown 11 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2020.
All research outputs
#15,605,323
of 23,202,641 outputs
Outputs from BMC Cancer
#4,179
of 8,417 outputs
Outputs of similar age
#219,636
of 357,279 outputs
Outputs of similar age from BMC Cancer
#66
of 166 outputs
Altmetric has tracked 23,202,641 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,417 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,279 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 166 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.